Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
"FDA updates on bulk drug substances nominated for use in compounding." FDA.gov, updated communications 2023
B.et al (1996)
Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications
GHK-Cu also downregulates pro-inflammatory cytokines like TNF-alpha and IL-6, reduces levels of fibrinogen (involved in inflammation), and blocks NF-kB and p38 MAPK activation
The 0.9% concentration is carefully chosen to balance two competing demands: Antimicrobial efficacy: The concentration must be sufficient to inhibit common lab contaminants, including gram-positive and gram-negative bacteria as well as common fungal species
